Hepatic

INDICATION: Liver disease

Mouse studies suggest inhibiting IKKα or its activator MAP3K14 could help treat liver disease.

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE